Cipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) NASDAQ: CPHR's share price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$12.70 and traded as high as C$13.17. Cipher Pharmaceuticals shares last traded at C$12.65, with a volume of 11,651 shares.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group set a C$12.50 price objective on Cipher Pharmaceuticals and gave the company a "hold" rating in a report on Monday.
View Our Latest Report on CPH
Cipher Pharmaceuticals Stock Performance
The company has a market capitalization of C$208.80 million, a P/E ratio of 12.84 and a beta of 1.20. The stock's fifty day moving average price is C$12.60 and its 200-day moving average price is C$14.10. The company has a debt-to-equity ratio of 41.22, a quick ratio of 2.67 and a current ratio of 2.00.
Insider Buying and Selling at Cipher Pharmaceuticals
In other news, Director Harold Morton Wolkin sold 3,500 shares of the stock in a transaction dated Monday, March 24th. The shares were sold at an average price of C$13.49, for a total value of C$47,215.00. Corporate insiders own 42.00% of the company's stock.
About Cipher Pharmaceuticals
(
Get Free Report)
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.
Featured Articles
Before you consider Cipher Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cipher Pharmaceuticals wasn't on the list.
While Cipher Pharmaceuticals currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
